Jane Street
KRYS icon

Jane Street’s Krystal Biotech KRYS Stock Holding History

Jane Street’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.03M Buy
24,300
+5,800
+31% +$1.73M ﹤0.01% 2957
2026
Q1 		$4.78M Sell
18,500
-11,900
-39% -$3.17M ﹤0.01% 3586
2025
Q4 		$7.49M Buy
30,400
+22,800
+300% +$4.8M ﹤0.01% 2683
2025
Q3 		$1.34M Sell
7,600
-57,900
-88% -$8.67M ﹤0.01% 5706
2025
Q2 		$9M Buy
65,500
+60,800
+1,294% +$8.93M ﹤0.01% 2267
2025
Q1 		$847K Sell
4,700
-21,600
-82% -$3.63M ﹤0.01% 5881
2024
Q4 		$4.12M Sell
26,300
-13,200
-33% -$2.34M ﹤0.01% 2936
2024
Q3 		$7.19M Buy
39,500
+13,300
+51% +$2.56M ﹤0.01% 2315
2024
Q2 		$4.81M Sell
26,200
-110,400
-81% -$18.5M ﹤0.01% 3019
2024
Q1 		$24.3M Buy
136,600
+67,200
+97% +$9.33M 0.01% 1048
2023
Q4 		$8.61M Buy
69,400
+58,600
+543% +$6.5M ﹤0.01% 2129
2023
Q3 		$1.25M Sell
10,800
-26,000
-71% -$3.17M ﹤0.01% 4830
2023
Q2 		$4.32M Buy
36,800
+15,900
+76% +$1.62M ﹤0.01% 2954
2023
Q1 		$1.67M Buy
+20,900
New +$1.64M ﹤0.01% 4136
2022
Q4 		– Sell
-8,800
Closed -$613K – 9659
2022
Q3 		$613K Buy
8,800
+2,800
+47% +$202K ﹤0.01% 6308
2022
Q2 		$394K Sell
6,000
-10,100
-63% -$628K ﹤0.01% 7158
2022
Q1 		$1.07M Buy
16,100
+3,500
+28% +$218K ﹤0.01% 5998
2021
Q4 		$881K Sell
12,600
-21,800
-63% -$1.27M ﹤0.01% 6158
2021
Q3 		$1.8M Buy
+34,400
New +$2.04M ﹤0.01% 4699
2020
Q3 		– Sell
-9,900
Closed -$410K – 7565
2020
Q2 		$410K Buy
+9,900
New +$476K ﹤0.01% 5376

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jane Street's KRYS Position: Q2 2026 in Review

Jane Street opened a new position in Krystal Biotech (KRYS) in Q2 2026: 956 shares worth $355K. The stake represents ﹤0.01% of the portfolio and ranks #8828 among its holdings. This is a return to the name: Jane Street previously reported a position in KRYS as recently as Q3 2025.

Jane Street first reported a position in KRYS in Q3 2019 and has held it in 16 quarters since. The position peaked at $16.7M in Q1 2024. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Jane Street held 956 shares of Krystal Biotech worth $355K as of Q2 2026.
  • Krystal Biotech was a new Jane Street position in Q2 2026.
  • Krystal Biotech made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8828 holding.
  • Jane Street first reported a position in Krystal Biotech in Q3 2019 and has held it in 16 quarters since.
  • Jane Street's Krystal Biotech position peaked at $16.7M in Q1 2024.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.